Ozempic Analog Mounjaro: Why Tirzepatide Outperforms Semaglutide in 2026

You've already heard about Ozempic. Maybe even considered trying it. Then you came across the name Mounjaro and now you don't understand: is this the same thing? Something better? Another marketing story?

Short answer: no, it's not the same thing. And the difference isn't cosmetic. These two products work differently at the molecular level, show different results in studies, and suit different people. Let's figure it out without unnecessary hype.

Why did Ozempic become so popular?

Ozempic received FDA approval in 2017 and quickly became the gold standard among GLP-1 agonists [1]. The active ingredient — semaglutide — mimics the natural hormone GLP-1, which is produced by the intestines after eating.

What semaglutide does in your body:

• Stimulates insulin production (only when blood sugar is elevated)
• Suppresses glucagon release
• Slows gastric emptying
• Affects satiety centers in the hypothalamus [2]

In other words, you eat less because you feel full faster. The stomach empties more slowly. And the brain receives signals that there's enough food.

The result? An average of 15% weight loss in clinical studies [2]. For a person weighing 100 kg, that's minus 15 kg. Not bad.

But there's a nuance. Ozempic acts only on one receptor — GLP-1. And this is where Mounjaro enters the picture.

In 2021, Ozempic (semaglutide 1 mg) received FDA approval for weight loss under the name Wegovy — and the market simply exploded. In 2022, Elon Musk publicly wrote that he "stays in shape with Ozempic". Pharmacists worldwide faced shortages. In the US, waiting lists for Wegovy were measured in months. It was in this context that Mounjaro appeared — as a more effective alternative.

In Ukraine, Ozempic (in the diabetes version, 0.5–1 mg) arrived earlier and captured the market faster. People saw results in acquaintances, read reviews — and started searching. But parallel to this, Mounjaro arrived with better clinical indicators. So today's comparison "Ozempic vs Mounjaro" is a question not only of effectiveness, but also of availability, price, and individual body response.

Mounjaro: what changed in 2022?

Mounjaro appeared on the market in 2022 as the first dual GIP/GLP-1 agonist [3]. The active ingredient — tirzepatide — works on two receptors simultaneously instead of one.

GIP (glucose-dependent insulinotropic polypeptide) is another intestinal hormone. It's produced by K-cells of the duodenum in response to food, especially carbohydrates and fats [5]. And it does something different from GLP-1:

• Affects adipose tissue metabolism
• Regulates fat storage and mobilization
• Improves insulin sensitivity in adipocytes
• Has receptors in bone tissue and brain [1]

When tirzepatide activates both receptors simultaneously, synergy occurs. SURPASS studies showed that tirzepatide improves insulin sensitivity and insulin response significantly more effectively than semaglutide [4].

The key difference of Mounjaro is dual agonism of GLP-1 and GIP receptors. Semaglutide (Ozempic) affects only GLP-1. Adding GIP provides a synergistic effect: satiety signals are amplified through two independent mechanisms simultaneously. It's like two brakes instead of one — stopping is more effective and smoother.

FDA approved tirzepatide (Mounjaro) for type 2 diabetes in May 2022, and for weight loss in November 2023 under the name Zepbound. In Ukraine, Mounjaro is present as an original Eli Lilly product. This is not a generic, not an analog, not a copy — this is the exact product that went through all clinical trials.

How much weight do people actually lose?

The numbers speak for themselves. And these aren't marketing promises, but results from direct comparative studies.

There aren't many direct head-to-head studies between semaglutide and tirzepatide yet, but indirect comparison speaks for itself. In STEP-1 (Wegovy 2.4 mg, 68 weeks): average loss — 14.9% body weight. In SURMOUNT-1 (Mounjaro 15 mg, 72 weeks): average loss — 20.9% body weight. The difference is 6 percentage points or ~5-7 kg with the same starting weight of 90 kg.

But there's a nuance: not everyone needs maximum results. If the goal is minus 10-12 kg and you don't have side effects at lower doses, this difference is less relevant. The choice between two products depends more on availability, price in your region, previous experience, and your specific body's response.

How dual mechanism works: science in simple terms

Let's dive deeper into the mechanism, because this is where the answer to "why is the difference so significant" lies.

GLP-1 receptors are located in the pancreas, stomach, and brain. When semaglutide activates them, you get:

• More insulin (when needed)
• Less glucagon
• Slower digestion
• Feeling of satiety [2]

But GIP receptors are a different story. They're present in adipose tissue, bones, heart, adrenal cortex, and brain [5]. When tirzepatide activates them additionally:

• Adipose tissue responds better to insulin
• Lipid metabolism changes
• Fat mobilizes more efficiently [1]

Researchers found that tirzepatide reduces insulin and glucagon concentrations after meals more effectively than semaglutide [4]. This means better blood sugar control with less "stress" on the pancreas.

Interestingly: both products equally reduce appetite. But tirzepatide still provides greater weight loss [4]. This indicates that it's not only about how much you eat, but also about how your body processes what you've eaten.

GLP-1 receptors are responsible for slowing gastric emptying, reducing glucagon production, and enhancing satiety. GIP receptors, which Mounjaro additionally affects, amplify this effect and have direct action on adipose tissue — they stimulate lipolysis, i.e., fat breakdown. That's why with equal calorie reduction on Mounjaro, muscle mass is more often preserved and more fat is lost specifically.

Practically: people on Mounjaro more often report that they "stopped thinking about food," while on Ozempic — "eat less but still think about it." This is a subjective difference, but important for daily program adherence.

What do you feel week by week?

The first weeks on either of these products are similar. And it's important to know this in advance.

Weeks 1-4 (starting dose):

• Possible nausea, especially first days
• Change in appetite — wanting to eat less
• Some feel mild stomach discomfort

Both products can cause gastrointestinal reactions: nausea, vomiting, diarrhea [2]. This is related to delayed gastric emptying. Usually these sensations decrease during the first weeks.

Weeks 4-12 (titration):

• Body adapts
• Side effects diminish
• Start noticing weight changes
• Food portions naturally decrease

Months 3-6:

• Stable weight loss
• New eating habits become normal
• More energy (less weight = easier movement)

If you missed a Mounjaro injection — take it as soon as possible within 4 days. For Ozempic, this window is 5 days. Then return to regular schedule [1].

For more details about what to expect, read the article about Mounjaro side effects.

The first week on Ozempic and Mounjaro is similar: mild nausea, decreased appetite, possible fatigue. Most people stabilize by the second week. The difference becomes noticeable from months 2-3: on Mounjaro, appetite decreases deeper and more stably. Clients describe this as "food stopped being the center of the day" — not just smaller portions, but less background interest in food.

Regarding social eating: on both Ozempic and Mounjaro, there are difficulties with fatty foods in the first months. Both products require attention to diet — not strict restrictions, but awareness. Alcohol on both enhances side effects and reduces effectiveness — better to avoid or minimize.

Who suits Mounjaro, and who suits Ozempic?

Honestly? Both products are effective. But there are situations when one might be a better choice.

Mounjaro might be better if:

• You need maximum effectiveness
• Ozempic didn't provide desired results
• You have insulin resistance
• You want to reach your goal faster

Ozempic might be an option if:

• You're already on it and satisfied with results
• There are medical contraindications to tirzepatide
• Your doctor specifically recommends it

Both products are NOT suitable if:

• You're pregnant or planning pregnancy
• You have personal or family history of medullary thyroid carcinoma
• You have multiple endocrine neoplasia type 2

Practical guide: if the goal is up to 12-15 kg, you don't have diabetes or prediabetes, and you want a proven product with a wide review base — Ozempic in the Wegovy version is an option. If the goal is over 15 kg, there are signs of insulin resistance, or you want maximum results with clinical data — Mounjaro provides more.

Detailed comparison of Mounjaro and Ozempic with tables and scientific data — on the Mounjaro vs Ozempic page.

DOZA offers specifically Mounjaro — the original Eli Lilly product with guaranteed cold chain. If you haven't decided yet or want to compare doses and costs — write to a specialist, and they'll select a program for your situation in 5 minutes.

Where to order Mounjaro in Ukraine

Ready to start the course? Buy Mounjaro in Ukraine in the DOZA catalog — all 6 doses (2.5, 5, 7.5, 10, 12.5, 15 mg) with official thermal delivery within 24 hours and 24/7 specialist support. Current Mounjaro prices 2026 — from 1,000 ₴ for a test dose or 8,000 ₴/month for a full program with monitoring.

Where to order DOZA products

DOZA supplies all products mentioned in the article with official cold chain and 24/7 specialist support. Choose what you need:

• Buy Ozempic in Ukraine — original semaglutide from Novo Nordisk with thermal delivery. Current Ozempic prices 2026 — from 1,600 ₴ for a starting dose.